QQ客服 官方微博 反馈留言

	Elevated serum OX40L is a biomarker for identifying corticosteroid resistance in pediatric asthmatic patients
	Ma Su-Li[1]; Zhang Lei[2]
刊名	BMC pulmonary medicine
	2019
卷号	19页码:66
关键词	Asthma Biomarker Inhaled corticosteroids (ICS) OX40 ligand (OX40L) Steroid resistance (SR)
ISSN号	1471-2466
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2161120
专题	上海大学
作者单位	1.[1]Department of Pediatrics, Pudong New District People's Hospital, Shanghai University of Medicine & Health Sciences, No.490 South Huanchuan Road, Pudong New District, Shanghai, 201200, China. 2.[2]Department of Pediatrics, Pudong New District People's Hospital, Shanghai University of Medicine & Health Sciences, No.490 South Huanchuan Road, Pudong New District, Shanghai, 201200, China. taizhouzl680511@126.com.
推荐引用方式 GB/T 7714	Ma Su-Li[1],Zhang Lei[2]. Elevated serum OX40L is a biomarker for identifying corticosteroid resistance in pediatric asthmatic patients[J]. BMC pulmonary medicine,2019,19:66.
APA	Ma Su-Li[1],&Zhang Lei[2].(2019).Elevated serum OX40L is a biomarker for identifying corticosteroid resistance in pediatric asthmatic patients.BMC pulmonary medicine,19,66.
MLA	Ma Su-Li[1],et al."Elevated serum OX40L is a biomarker for identifying corticosteroid resistance in pediatric asthmatic patients".BMC pulmonary medicine 19(2019):66.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。